A new secret-shopper study found that GLP-1 prescriptions from telehealth sites aren't often backed by appropriate clinical ...

States across the country saw steep drops in the number of people covered by the Affordable Care Act over the past year, ...

Vertex Pharmaceuticals will spend $10 billion to acquire Crinetics Pharmaceuticals and its drug for a rare endocrine disorder ...

Call AI in biotech hype at your peril. There are real reasons that pharmaceutical companies are embracing this technology ...

Rose covers disability and mental health, and she helps write STAT’s daily Morning Rounds newsletter. Confidential tips can be sent to Rose on Signal at rosebroderick.11. Annalisa (Nalis) Merelli is ...

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — Clinical trial policy ...

Dozens of congressional lawmakers are urging the Trump administration to force Eli Lilly to reinstate mandated price breaks ...

Colorado Democratic Rep. Diana DeGette, who lost her primary, was knowledgeable about biopharma, if not always a friend to ...

Bluebird Bio was a dark biotech morality tale when David Meek bought it. He says the new company, Genetix, is already making ...

CDC leadership continues to try manufacture a scientific debate on vaccines where none exists, writes Ben Lopman.

Reducing Medicare payments for 340B drugs is the latest proposal focused on the hotly debated drug discount program.

Elevance Health has sued the U.S. government, alleging that federal efforts to recalculate its Medicare Advantage quality ...